Personalized Medicine in Gynecology and Obstetrics

Dear Colleagues,

Personalized medicine is set to transform obstetrics and gynecology by emphasizing individualized care tailored to genetic, environmental, and lifestyle factors. The objective of this Special Issue is to compile research that advances clinical practice by tailoring medication administration methods and therapy approaches to the individual needs of patients.

We invite submissions of original research articles and review papers focused on techniques for early detection of genetic disorders, fetal risk assessment, and fetal health monitoring. Furthermore, we are open to exploring metagenomics and epigenetics, with an emphasis on how the microbiome and epigenetic changes affect treatment options and pregnancy outcomes. Pharmacogenomics, which adjusts drug regimens to genetic profiles for better efficacy and safety, is another topic of interest.

In addition, we are interested in research on personalized endocrine therapies in gynecological health, including the latest approaches for diagnosing and managing uterine fibroids and endometriosis. Other key topics include cancer risk assessment through genetic testing for evaluation and prevention and personalized fertility treatments. The critical importance of screening and preventive care, as well as the development of new diagnostic tools and techniques, round out our focus areas.

We look forward to receiving your contributions.

Dr. Mǎdǎlin Marius Margan
Dr. Florin Gorun
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.